Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study
Authors:
- Bu B YeapBYBu B Yeap
- S A Paul ChubbSCS A Paul Chubb
- Kieran A McCaulKMKieran A McCaul
- Ken K Y HoKHKen K Y Ho
- Graeme J HankeyGHGraeme J Hankey
- Paul E NormanPNPaul E Norman
- Leon FlickerLFLeon Flicker
- 1 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 164 (5) , 715-723
Abstract
Objective: Circulating IGF1 declines with age while ill-health increases. Controversy remains whether differences in the levels of IGF1 and its binding proteins 1 and 3 (IGFBP1 and IGFBP3) determine health outcomes during ageing. We examined associations of IGF1, IGFBP1 and IGFBP3 with all-cause and cardiovascular mortality in older men.Design: We conducted a prospective cohort study of community-dwelling men aged ≥70 years.Methods: Plasma collected at baseline (2001–2004) was assayed for total IGF1, IGFBP1 and IGFBP3. Incidence and causes of death from time of recruitment to 31 December 2008 were ascertained using the Western Australian Data Linkage System. Cox regression analyses were performed, adjusting for conventional cardiovascular risk factors.Results: Among 3983 men followed for 5.2 years (median), 694 deaths occurred, 243 from cardiovascular disease (CVD). There was no difference in survival according to quintiles of IGF1. Increased IGFBP1 predicted increased all-cause mortality (highest versus lowest quintile: adjusted hazard ratio (HR)=1.98, 95% confidence interval (CI)=1.52–2.57, PPP=0.007 for trend). Associations of IGFBP1 and IGFBP3 with all-cause mortality were not attenuated by adjustment for IGF1 levels.Conclusions: In older men, higher IGFBP1 and lower IGFBP3 levels predict overall and CVD-related mortality, while IGF1 levels are not associated with mortality. Further studies are needed to clarify the underlying mechanisms by which IGFBP1 and IGFBP3 levels are associated with mortality risk, and whether this occurs independently of IGF1.Keywords
This publication has 40 references indexed in Scilit:
- The Role of Liver-Derived Insulin-Like Growth Factor-IEndocrine Reviews, 2009
- Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjectsEuropean Journal of Endocrinology, 2008
- Growth Hormone Treatment on Atherosclerosis: Results of a 5-Year Open, Prospective, Controlled Study in Male Patients with Severe Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Aging and the growth hormone/insulin like growth factor-I axisPituitary, 2007
- Association of Total Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1), and IGFBP-3 Levels with Incident Coronary Events and Ischemic StrokeThe Journal of Clinical Endocrinology & Metabolism, 2007
- Insulin-Like Growth Factor (IGF) I, -II, and IGF Binding Protein-3 and Risk of Ischemic StrokeThe Journal of Clinical Endocrinology & Metabolism, 2005
- Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3, and Cardiovascular Disease Risk Factors in Young Black Men and White Men: The CARDIA Male Hormone StudyAmerican Journal of Epidemiology, 2004
- Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart StudyAnnals of Internal Medicine, 2003
- Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart DiseaseCirculation, 2002
- Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 1998